Nagarjuna Fertilizers and Chemicals Ltd Q1 FY27 Results

Nagarjuna Fertilizers and Chemicals reported a consolidated net loss of ₹5.56 Cr for Q1 FY27 (quarter ended June 30, 2026), against zero revenue from operations for yet another quarter since the company's core and non-core assets were sold under an ACRE-controlled debt settlement, effective Q1 FY25. Standalone and consolidated figures are identical, since the lone associate, KVK Raju International Leadership Ltd, reported nil revenue and income for the quarter and was assessed immaterial to the group by auditors P. Murali & Co.

The entire loss stems from ₹6.16 Cr of expenses run against just ₹0.60 Cr of other income, since there is no revenue base to offset — finance cost of ₹1.24 Cr and employee benefit expense of ₹1.38 Cr are the largest lines, with no tax charge given the loss. YoY, the loss narrowed about 11% from ₹6.26 Cr in Q1 FY26, but QoQ the picture reversed sharply: Q4 FY26 had shown a ₹1.51 Cr profit, aided by an urea subsidy de-escalation credit and much higher other income (₹8.78 Cr) that quarter. Absent similar one-off credits this quarter, the company swung back to loss — a QoQ move that is a one-off artifact, not an operating trend, given there is no underlying business generating revenue.

For context: revenue is at a 6-quarter high.

EPS -₹0.09 (basic/diluted, not annualised) vs -₹0.10 a year ago and +₹0.03 the prior quarter

Auditors' Emphasis of Matter reiterates the financials are prepared on a 'not a going concern' basis, with current liabilities exceeding current assets by ₹880.57 Cr (Note 4) even before disputed energy and government claims are considered. Contingent liabilities stand at roughly ₹1,314.98 Cr (Note 5), dominated by long-running GAIL arbitration and Office Memorandum disputes plus a ₹836.67 Cr royalty claim from related party NACL over trademark use — a dispute in which the company recently lost its Bombay High Court appeal against a GAIL-linked arbitration award (per company filings dated June 24, 2026). The results were themselves delayed from schedule, with the company citing 'financial constraints' on August 14, 2026, before being approved on August 30, 2026, shortly after the FY26 audited results were cleared on June 30, 2026.